Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol., 15 October 2025

Sec. Nanobiotechnology

Volume 13 - 2025 | https://doi.org/10.3389/fbioe.2025.1668888

Construction of bioactive nanocomposites from beta-sitosterol, fucoidan, chitosan, and silver nanoparticles for anticancer applications

Ahmed A. Tayel
Ahmed A. Tayel1*Fatma K. ElagezyFatma K. Elagezy1Asmaa AbdellaAsmaa Abdella2Hend A. GadHend A. Gad1Mohamed E. El-HefnawyMohamed E. El-Hefnawy3Sultan Alhayyani
Sultan Alhayyani4*Shaymaa W. El-FarShaymaa W. El-Far5
  • 1Department of Fish Processing and Biotechnology, Faculty of Aquatic and Fisheries Sciences, Kafrelsheikh University, Kafrelsheikh, Egypt
  • 2Department of Industrial Biotechnology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, El-Sadat City, Egypt
  • 3Department of Marine Chemistry, Faculty of Marine Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
  • 4Department of Chemistry, College of Sciences and Arts, King Abdulaziz University, Rabigh, Saudi Arabia
  • 5Division of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia

Introduction: Cancers (e.g., colon and skin cancers) are significant causes of mortality. We developed novel anticancer nanocomposites comprising natural bioactive compounds and metal nanoparticles, involving conjugation of beta-sitosterol (BSt) and fucoidan (Fu), for biogenic synthesis of silver nanoparticles (AgNPs), before conjugation with chitosan (CS), to generate potential innovative anticancerous nanocomposites.

Methods: The fabricated Fu/BSt/AgNPs/CS nanocomposites were characterized for efficacy against colon cancer (HCT-116) and skin cancer (A375) cells. Electron microscopy (SEM and TEM), FTIR infrared spectroscopy, DLS analysis and UV-Vis spectroscopy, confirmed the synthesis and interactions within nanocomposites. The MTT assay and dual staining validated the potential nanocomposites’ actions as anticancerous materials, compared to “cisplatin”.

Results and discussion: AgNPs had a mean diameter of 8.83 nm, whereas Fu/BSt/AgNPs/CS had 146.6 nm size. MTT assay revealed that IC50 of Fu/BSt/AgNPs and Fu/BSt/AgNPs/CS nanocomposites were 16.23, 12.75 mg/L against HCT-116 cells, and 34.81, 22.44 mg/L against A375 cells, respectively, which significantly exceeded the cisplatin IC50 (25.56 and 79.77, respectively). The cancer cells’ treatment with nanocomposites revealed significant apoptosis induction and cell growth inhibition. Ultra-structural imaging confirmed the nanocomposites’ ability to trigger cancer cells to undergo morphological alterations, destructions and collapse. Invented Fu/BSt/AgNPs/CS nanocomposites have great promises as safe and effective treatments for colon and skin cancers, generated from natural compounds.

1 Introduction

Cancer has historically been and continues to be the second leading cause of death worldwide, with millions of new cases annually (Nandi et al., 2024), making it a significant global public health concern (Siegel et al., 2022). Cancer is a medical condition that affects people all around the world and is distinguished by abnormal cell proliferation resulting from various changes in gene expression, including mutations in adult stem cells that can divide and multiply throughout postnatal life (Jiang et al., 2025). The estimated new cancer cases worldwide in 2015, 2020, 2022 and projection of 2025 are totally ∼17.5, 19.3, 20.0, and 21.1 million, including Colorectal (Colon and Rectum) Cancer with ∼1.7, 1.9, 2.1 and 2.3 million, whereas the new cases of skin cancer (Melanoma and Non-Melanoma) are 4.1, 5.2, 6.6 and 7.7 million, respectively (Siegel et al., 2022; Jiang et al., 2025). This class of diseases, which occurs in higher multicellular organs, is associated with alterations in the expression of multiple genes, leading to the disruption of normal programmed cell division and differentiation (Jiang et al., 2024). Ultimately, this leads to an imbalance in the control of cell division and death, which permits malignant cells to in-filtrate other organs and spread to far-off locations (Ji et al., 2021), promoting the growth of tumor cell mass (Islam et al., 2022; López Ruiz et al., 2020). The key managing approaches of cancers involve surgery, chemotherapy and radiotherapy, which could induce numerous serious side-effects, where their curative impacts are limited. Thus, the explorations of less toxic substances from natural origins are always research priorities of scientists. The potentiality of natural derivatives to target definite signaling pathways was proposed for inhibiting/delaying the carcinogenesis development at diverse phases; natural phytocompounds have also the ability to provide elevated functionality and specificity, lower cytotoxicity, and selective induction of apoptosis in cancerous cell (Jiang et al., 2025; Islam et al., 2022; Rytsyk et al., 2020).

The colon is an essential part of the human body as it is a lengthy tube that joins the rectum and small intestine.Its length can vary between 1 and 150 cm (5 and 6 ft) and together with the rectum, makes up the large intestine. This specialized organ is responsible for breaking down and storing waste before releasing it into the rectum for defecation to occur (Rytsyk et al., 2020). Colorectal cancer is the third leading cause of cancer anywhere and when detected early, it can be cured through surgery. However, advanced cases are often fatal, with liver metastases accounting for most of the deaths. Genetic mutations and oncogenes are recognized as aiding the development of colorectal cancer (Khan and Anwar, 2019). Additionally, it ranks as the second most frequent cause of cancer-related mortality among people, with increasing numbers worldwide each year. It also considered a common tumor in the gastrointestinal tract, responsible for 6% of new cancer diagnoses and 5.8% of cancer-related deaths worldwide each year (Zhang et al., 2022). Only 70% of colorectal tumors are operable when initially diagnosed, with a 75% chance of cure for those cases (Zhu et al., 2024). However, operable patients have a 25% probability of getting sick again. Nineteen percent of individuals have advanced illness at diagnosis. Every year, about 250,000 new instances of colon cancer are detected in Germany, accounting for 9% of all cancer cases. While it has been more prevalent in wealthy nations, it is also becoming increasingly prevalent in middle-class and low-income nations (Rytsyk et al., 2020; Zhang et al., 2022). Treatment for colon cancer usually involves surgery and chemotherapy, but these treatments can sometimes be ineffective. The treatments of colorectal cancers with natural and biological derivatives/compounds were suggested as potential effectual approaches fo managing these cells (Islam et al., 2022; Rytsyk et al., 2020; Zhang et al., 2022; Zhu et al., 2024).

The skin is the largest and the primary defense organ of body (Peate, 2021).Melanoma, a type of skin cancer, is becoming increasingly common and has a rapidly rising death rate (Liu et al., 2022). This aggressive disease can infiltrate lymph vessels and spread quickly, reaching other parts of the body through blood vessels. For example, melanocytes can enter lymph nodes and move to the lungs, posing a significant danger (Alves et al., 2024). The applications of natural derivatives, especially in nanoforms, are recurrently recommended for treating/managing the skin cancers (Peate, 2021; Liu et al., 2022; Alves et al., 2024).

Fucoidan (Fu), a polysaccharide comprising sulfated fucose residues, is abundant in marine life, particularly brown algae, where it is among the numerous bioactive molecules found (Díaz- et al., 2023). Numerous studies have been conducted on fucoidan’s anticancer effects. Basic research studies have demonstrated a several biological functions, including as antioxidant, anticancer, and anti-inflammatory anti-Helicobacter pylori, antiangiogenic, antiviral, antithrombotic, and anticoagulant effects (Zahariev et al., 2023). The sulfated nature of Fu advocated its role as antimicrobial, scavenging agent and anticancerous biopolymers, in addition to its potentiality for mediating diverse metals nanoparticles and conjugating them to provide more effectual bioactive nanocomposites (Rajeshkumar, 2017; Sacramento et al., 2022; Rajeshkumar et al., 2021; Li et al., 2022). Fucoidan can kill malignan-cies directly by causing apoptosis, cell cycle arrest, and other reactions. It can also kill cancer cells indirectly by enhancing the activity of natural killer cells, macrophages, and others (Rajeshkumar et al., 2021; Li et al., 2022; Hsiao et al., 2022; Namvar et al., 2013). Fucoidan’s potent biological activity, broad availability, low vulnerability to drug resistance, and low side effects make it a desirable choice for usage as a new an-ti-tumor agent or as an adjuvant in conjunction with current therapies (Zahariev et al., 2023; Sacramento et al., 2022).

Phytosterols (PS) include ß-sitosterol (BSt), a bioactive food component that may possess potential for cancer prevention and treatment by impacting various regulatory mechanisms. Studies have indicated that BSt, derived from plants, has demonstrated anticancer characteristics that protect against stomach, lung, colon, prostate, skin, and leukemia malignancies. Furthermore, ß-sitosterol has been found to have minimally harmful anti-inflammatory, anticancer, hepatic protecting, antioxidant, cardio protective and antidiabetic properties through pharmacological screening. It has also been observed to interfere with multiple cellular pathways of communication, involving invasion, survival, metastasis, angiogenesis, apoptosis, proliferation, and phase of cell. Furthermore, the compound has displayed antioxidant activity by scavenging free radicals 2,2-diphenylpicrylhydrazyl (DPPH) (Alvarez-Sala et al., 2019; Bao et al., 2022).

Natural polymers are regarded as eco-friendly alternatives and are extensively utilized across Because of their non-toxic, sustainable, and renewable qualities; they are used in the food, medicinal, related to farming, and ecology sectors (Yu et al., 2020). Chitosan (CS), a bioactive deacetylated form of chitin, has been effectively extracted from various sources, including crustacean waste, fungal mycelia, and insect exoskeletons (Aranaz et al., 2021). Chitosan nanoparticles (CS-NPs) have gained increasing attention for their potential uses in crops fertilization, disease prevention, preservation of the earth, medication encapsulation and delivery, and health protection (Jhaveri et al., 2021). Chitosan and its derivatives are recognized as promising natural polysaccharides with anticancer potential. Extensive efforts to discover effective anticancer agents from natural sources have led to growing interest in polysaccharides. The bioactive properties of CS have driven its widespread use in various biomedical applications, including antimicrobial formulations, tissue design, anticancer therapy, administration of medications, and dressings for wound healing (Alalawy et al., 2020).

The unique characteristics of AgNPs make them valuable in tissue engineering. Different biomaterials have been created for various purposes, particularly because of their diverse reactions, modes of action, biodegradability, and biocompatibility (Tayel et al., 2021). In vitro models are fast, convenient, cost-effective, and helpful for assessing cytotoxicity, genotoxicity, biocompatibility, and effectiveness and performance (Zhang et al., 2016). Numerous investigations reported the usages of natural components as anti-cancerous bases (Jiang et al., 2025; Islam et al., 2022), including β-sitosterol (Nandi et al., 2024; Alvarez-Sala et al., 2019; Bao et al., 2022), AgNPs (López Ruiz et al., 2020; Rajeshkumar, 2017; Zhang et al., 2016) fucoidan (Zahariev et al., 2023; Rajeshkumar, 2017; Rajeshkumar et al., 2021; Hsiao et al., 2022) and chitosan (Yu et al., 2020; Aranaz et al., 2021; Jhaveri et al., 2021; Alalawy et al., 2020), involving their nanoparticles and nanocomposites. Perceived insufficiency and inconsistency were reported from such natural compounds, addressing the need for deep and detailed investigations to develop more effectual combinations from them (Jiang et al., 2025; Islam et al., 2022).

This study aims to prevent cancer and provide potential anticancer alternatives from natural sources by exploring dietary and natural biomolecules, as well as nanomaterials, with the potential to reduce cancer incidence and progression, offering promising substitutions to traditional chemotherapy. The aim was to develop formulations with strong anticancer effects that could contribute to effective cancer treatments with minimal side-effects. Nanocomposites combining beta-sitosterol, fucoidan, chitosan and silver nanoparticles are generated using biogenic and polyelectrolyte compositing approaches, characterized, and tested for their anticancer properties against skin and colon cancer cell lines.

2 Materials and methods

2.1 Fucoidan extraction

The fucoidan (Fu) extracting involved the algal material dehydration, grinding then sterol was used to extract lipids, phenols, and terpenes. Extraction with ethanol (99%) and water is used to remove lipids and polysaccharides, followed by the use of an ethanolic solution to extract aldehyde, mannitol, chlorophyll, proteins, polyphenols, and nucleic acids (Ptak et al., 2021). After extraction, the precipitate was washed and heated. A chemical extraction process was then used to extract crude fucoidan by using a 1:20 ratio of (seaweed: extracting liquid) and 0.1 M HCl (37%) solution, heated at 70 °C and centrifuged “SIGMA 2–16 KL centrifuge; Sigma Lab. GmbH, Germany” at 10.500 xg for 10 min. NaOH solution was added to reach pH 7.0, followed by purifying procedures, involved the drying and milling of alginate into a powder after being treated with weak HCl to create alginic acid. To precipitate Fu and eliminate salts and small particles, 3 vol of cold ethanol was added (Costa et al., 2021). Cetyltrimethylammonium bromide (CTAB; ≥96.0%, Molecular Weight:364.45 Da; Merck, Germany) can be added during the extraction process to facilitate DNA isolation and separation of proteins. FTIR analysis was then conducted to confirm the extraction of Fu (Zayed et al., 2020).

2.2 Preparation of fucoidan and beta-sitosterol (Fu/BSt) composite

The preparation of Fu/BSt composite involved the intermixing of equal volume and concentrations of Fu and BSt under stirring “AREX-6; VELP Scientific Srl., Italy”. BSt (e.g., 0.75 g) was dissolved in 100 mL of 90% ethanol at room temperature for 45 min, whereas the same concentration was made from Fu in deionized water. Finally, equal volume of the solutions was mixed and stirred (620 xg) for 140 min to synthesize Fu/BSt composite. The composite were then vacuum-dried and milled.

2.3 Synthesis of Fu/BSt/AgNPs/CS nanocomposite

To prepare silver nanoparticles (AgNPs), a 10 mM solution of AgNO3 (≥99.0% purity; Merck KGaA, Darmstadt, Germany) was prepared in deionized water, and from chitosan (molecular weight = 50–190 kDa; Deacetylation degree = 75–85%; viscosity = 20–300 cP; Merck KGaA, Darmstadt, Germany), chitosan solution of 1.0% concentration (w/v) was prepared in 1.5% acetic acid aqueous solution. The Fu/BSt solution was made (1.0%, w/v) in deionized water. For the synthesis of the nanocomposite, equal volumes of Fu/BSt and AgNO3 (1:1) solutions were mixed and stirred using a magnetic stirrer (620 xg) for 3 h without heating. The pH of solution was adjusted to 8.5 via NaOH solution (0.1 M) dropping. Subsequently, equal amounts (e.g., 20 mL) of chitosan solution were slowly dropped into stirred Fu/BSt/AgNPs solution to complete the synthesis of the Fu/BSt/AgNPs/CS nanocomposite.

2.4 Fu/BSt/AgNPs/CS nanocomposite characterization

2.4.1 NCs’ optical characterization

Using a UV-Vis spectroscopic examination (UV-2450, Shimadzu, Japan) at ranges between 200 and 800 nm, the formation of the Fu/BSt/AgNPs/CS nanocomposite was confirmed, and the absorbance wavenumber (λ max) for solutions with molecules that work together was measured.

2.4.2 Fourier transform infrared (FTIR) spectroscopy

Using an infrared spectrometer (J FTIR; JASCO FT-IR-360, Japan), FTIR analysis provided data on the biochemical bonding between Fu/BSt/AgNPs and CS as well as their interactions in the composite. The solutions were processed into a powder, and combined with KBr before analysis. After that, the assessed molecules’ infrared transmission patterns appeared across a wavenumber range of 450–4,000 cm−1.

2.4.3 Particles’ size (Ps) and zeta (ζ) potential appraisal

Using DLS “dynamic light scattering” and photon correlation spectroscopy techniques, the Ps distribution and surface charges (ζ potential) of synthesized NPs/NCs were evaluated using the Zetasizer (MalvernTM, Malvern, United Kingdom).

2.4.4 The electron microscopy imaging

Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used to examine the distribution, particle size (Ps), and optical shape of particles. The SEM (IT100, JEOL, Japan) was employed for scanning imaging, and the accelerating voltage was set to 10 kV. The nanocomposite suspensions were sterilized, assigned to self-adhesive carbon discs, and covered with a palladium/gold coating using a Polaron Inc. E5100 II sputter coater (Hatfield, PA) with the aim to get them suitable for SEM analysis. A TEM microscope “JEOL JEM-100CX, Japan” was used to evaluate the aqueous dispersions of the nanocomposites at an applied voltage of 200 kV after they were drop-cast onto carbon-coated copper grids and allowed to air dry at their natural temperature.

2.5 Monitoring a biological activity of cancer therapy

2.5.1 Lines of cancerous cells

Our source for the HCT 116 and A375 cell lines was the ATCC “American Type Culture Collection, Rockville, United States.” 10% fetal bovine serum (FBS; Sigma Chemical Co., MO, USA) was added to RPMI1640, also known as “Roswell Park Memorial Institute medium,” in which the cells were cultivated. The cells were kept in an incubator with 5% CO2 at 37 °C in monolayer form. To evaluate the antitumor activity, triplicated experiments were conducted, where cisplatin was employed as a control drug for comparison.

2.5.2 Cytotoxicity assays

The cytotoxicity assessments were conducted in the GEBRI-USC “Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Egypt”, by specialized technicians. Mitochondrial function and cell viability were assessed using the MTT assay (Forma and Bryś, 2021). In summary, 1.0 × 105 cells per well were impregnated into a 96-wells plate, and the cells were incubated for 24 ± 1 h under the previously mentioned conditions (5% CO2 at 37 °C). Cell-containing wells were treated with Fu/BSt/AgNPs/CS (T1, T2, and T3) at varying concentrations (e.g., 0–100.0 μg/mL). Following treatment, MTT solution served for heating the cells; 5.0 mg/mL solution of MTT “3-(4,5 Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide” was put into the inoculating wells, and they were incubated for additional 4 h. After removing the media from the wells, 100 μL of DMSO was transferred per well. The color of wells contents was then assessed colorimetrically (at 570 nm), after 30 min of moderate vortexing (El-Sherbiny et al., 2023). The anticancer activity of Fu/BSt/AgNPs/CS nanocomposites (at IC50 concentration) against A375 cells were further tracked using dual staining “acridine orange/ethydium bromide staining” (Alalawy et al., 2020; El-Sherbiny et al., 2023). The A375 cells (∼6 × 104 cells) were treated by IC50 of Fu/BSt/AgNPs/CS nanocomposites and incubated for 24 h, 48 h, in addition to control treatment (only media) in 5% CO2 humidified air at 37 °C. Cells were bathed after treatment with phosphate buffer, and then were dual stained for 15 min with 4 μg/mL from each of acridine orange and ethydium bromide in dark. The fluorescence microscope “Olympus BX51, Tokyo, Japan” worked for capturing cells images to emphasize the immergence of apoptosis signs, e.g., the cells/organelles with green-, orange-, or red-stains, within 20–25 min from staining.

2.6 Scanning electron microscopy (SEM) imaging

Electron microscopy, particularly SEM, is a crucial process for examining the morphological characteristics and surface features of cancer cells, enabling detailed visualization of organelles and other cellular structures. Tumor cells often exhibit abnormal ultrastructural protrusions and self-assembled surface features that are not detectable under light microscopy but can be revealed through SEM. These surface architectures are critical for cell migration and motility, and by highlighting interactions between cells and their microenvironment, they provide key insights into cancer biology. Furthermore, the treatment led to a notable rise in apoptotic cells, confirming the anticancer properties of the nanocomposite (Venkatesan et al., 2017).

2.7 Statistical analysis

The assessment of nanomaterials’ characteristics and their biological (anticancer) activity were conducted in triplicates. The three replicates’ means were computed with Microsoft excel 2010. The unpaired t-test and one-way ANOVA was carried out, and the SPSS software program “V 17.0, SPSS Inc., Chicago, IL” was used to assess the significance of the results at p < 0. 05.

3 Results and discussion

3.1 Visual and optical identification

Fu/BSt/AgNPs composite was initially negative in charge, but upon mixing with chitosan, which carries a positive charge, a new composite, Fu/BSt/AgNPs/CS, was formed. The synthesis of the Fu/BSt/AgNPs/CS nanocomposite involved four key stages: (1) formation of the Fu/BSt composite solution, (2) preparation of the silver solution, (3) Within 45 min of mixing the two solutions, the color shifted to black, further confirming AgNPs, and (4) conjugation with CS to achieve to verify the Fu/BSt/AgNPs/CS tiny particles’ biogenesis.

Using Fu/BSt to verify the biosynthesis of AgNPs, UV-Vis spectroscopy was employed (Figure 1). Where the upper photos in Figure 1 reflected the color change (from bale yellow to dark brown) after the biosynthesis and reduction of AgNPs with Fu/BSt, the lower curve represents the UV spectrum of nanomaterial solution color, associated with AgNPs. The distinct surface plasmon resonance (SPR) peak of the AgNPs solution, with a λ max near 426 nm, indicated the successful biosynthesis of the nanocomposites (Yao et al., 2022).The color change of the biosynthesized AgNPs solution is typically associated with the size, dispersion, and morphology of the nanoparticles, as well as the reducing agents used (Menon et al., 2018).

Figure 1
Graph showing absorbance versus wavelength with a prominent peak at 426 nanometers. An arrow points from a yellow liquid to a black liquid, indicating a color change.

Figure 1. Visual aspects and UV-Vis spectrum of biosynthesized Fu/BSt/AgNPs nanocomposite.

3.1.1 Infrared analysis of materials/nanocomposites

The FTIR analysis provides detailed insights into the molecular structure, functional groups, and interactions of the compounds under investigation (Figure 2). The IR spectra of the Fu, BSt, and their composites with AgNPs showed characteristic peaks that reflect the functional groups of the individual components, with some peak intensities altered as a result of interactions between them. The highlighted parts indicating the transferred, vanished or emerged bands after conjugation and interaction between conjugated materials.

Figure 2
FTIR spectra graph showing transmission percentages for BSt, Fu, Fu/BSt, and Fu/BSt/AgNPs. The x-axis is wavenumber in inverse centimeters from 4000 to 500. Colored bands highlight specific peaks: blue for BSt, red for Fu, yellow for Fu/BSt, and green for Fu/BSt/AgNPs.

Figure 2. Infrared spectral analysis (FTIR) of fucoidan (Fu), beta sitosterol (BSt), fucoidan, beta sitosterol and silver nanoparticles Fu/BSt/AgNPs.

For fucoidan (Fu), the key IR bands in this spectrum are detected at 1,556.6 cm−1, peaks representing groups of sulfides were detected, and at 1,038.2 cm−1 and 1,039.7 cm−1, they are ascribed to the extension motion of the C‒O‒S the central C4 locations with sulfate replacements. Peak number two at 1,558.8 cm−1 is associated with C‒H stretching of the pyrenoid ring, as well as the C-6 group of fructose and galactose (Figure 2). The asymmetric stretching of the sulfate group (O=S=O) is seen at 1,039.7 cm−1 (Yu et al., 2024). Additionally, while the band at 3,000 cm−1 represents C‒H stretching from the pyrenoid ring, a large peak focused at 3,433 cm−1 represents the bonded O‒H stretching vibration, and stretching of the glycosidic links from C to O to C. Peaks at 1750 cm−1 and 1,540 cm−1 are associated with the stretching vibrations of sulfate esters. The sulfide group’s C‒O‒S bending vibration is responsible for the band at 1,300 cm−1, while the bands at 590 cm−1 indicate the asymmetric and symmetric O=S=O deformation of the sulfate group. The FTIR spectrum demonstrated the success of the procedures used for getting rid of fucoidan from brown algae. Additionally, the asymmetric carboxylate O‒C‒O contraction is represented as a peak at 2,200 cm−1 (Narayani et al., 2019).

For beta-sitosterol (BSt), the infrared spectra showed notable absorbance peaks at 1749.9 cm−1 (C=C expanding), 2,959 cm−1 and 2,868.72 cm−1 (CH3), 2,868.72 cm−1 and 2,852.27 cm−1 (CH2), and 3,600 cm−1 (OH). Of the unconjugated olefin), and 1700 cm−1 (C‒OH deformation, associated with O‒C‒O symmetric stretching) Figure 2-BSt). Other notable bands include those for the secondary alcohol (C-OH) at 1,100 cm−1, the gem-dimethyl group (-CH(CH3)2) at 1,390 cm−1, and the cyclic methylene groups (CH2) at 1,484.5 cm−1 (Ododo et al., 2016).

According to the interaction between fucoidan and beta-sitosterol, the FTIR spectrum of the composite showed key adsorption features (Figure 2-Fu/BSt). A peak at 1,086 cm−1 was ascribed to the expanding of the C‒H‒O bond in alcohol and phenol compounds. The alcohol component’s C‒OH stretching vibrations Peaks at 1,086 cm−1 and 1,049 cm−1 confirmed the extract and nano-carrier, accordingly. Around 666 cm−1 and 881 cm−1, the bending frequencies linked to the C–H bonds in C–C–H classes were detected.

The FTIR spectrum of the Fu/BSt/AgNPs composite revealed distinct peaks at O-H and -NH2 stretching (3,359.22 cm‒1), C-H stretching (2,927.92 cm‒1), and -C-H stretches (2,838.25 cm‒1) (Figure 2-Fu/BSt/AgNPs). Additional noteworthy peaks are as follows: CH stretch (2,736.18 cm−1), C=O stretching (1,647.49 cm−1), ‒CONH2 (1,588.05 cm−1), OH bending (1,375.44 cm−1), C-N stretch (1,149.10 cm−1), C‒O stretching (1,079.13 cm−1), and 893.01 cm−1 (saccharide ring vibration) (Ata et al., 2025). The FTIR spectrum of the Fu/BSt/AgNPs nanocomposite further confirms the successful formation of the nanocomposite through characteristic shifts and the appearance of new peaks. After the synthesis of Fu/BSt/AgNPs, several changes in the spectra were observed. Notably, the disappearance of certain peaks, such as those related to the functional groups of fucoidan and beta-sitosterol (highlighted in yellow), suggests that some bonds were disrupted or altered during the nanoparticle synthesis process. This indicates that the silver nanoparticles are interacting with the biomolecules, leading to a modification of the original functional groups. Moreover, the emergence of new peaks (highlighted in green) in the Fu/BSt/AgNPs spectrum suggests the creation of fresh chemical connections between the proteins and the silver nanoparticles. These new peaks are indicative of the successful conjugation of AgNPs with the composite, confirming the formation of a stable nanocomposite material. The changes in the FTIR profile, including the shift in peak positions and the appearance of new absorption bands, strongly support the conclusion that the AgNPs are effectively integrated into the Fu/BSt matrix, forming a well-structured nanocomposite.

The highlighted zones in Fu/BSt spectrum are transferred from Fu (red zones) and from BSt (blue zones), whereas the highlighted parts in Fu/BSt/AgNPs with yellow indicated the vanished/disappeared peaks and the green zones are the emerged peaks after AgNPs biosynthesis and interaction with Fu/BSt.

3.2 Particles’ sizes and zeta (ζ) potential of fabricated nanomaterials

The DLS technique (Table 1) was used to demonstrate the diameters (Ds) and surface charges (ζ potential) of nanomaterials. It demonstates that each of the AgNPs, Fu/BSt, CS, and Fu/BSt/AgNPs/CS composite were negatively and positively charged as follow, - 23.45, - 26.18, +34.96, and +24.52 mV, respectively. As the higher values (>30 mV) results in higher NPs stability and dispersion, the DLS and TEM results matched for the screened nanoparticles (Figure 1), and their potentials might result in higher stabilities for manufactured nanocomposites (Khan and Anwar, 2019; Hou et al., 2022). The TEM imaging of the produced nanoparticles demonstrated their stability and good dispersion (Figure 1). AgNPs’ mean diameter was 7.23 nm, demonstrating the potent reduction activities of Fu/BSt that produced such small sizes. The mean Ds of Fu/BSt/AgNPs/CS composites (130.61 nm) was slightly greater than the mean Ds of individual Fu/BSt and AgNPs, which suggests the encapsulation of AgNPs within Fu/BSt particles (as earlier appointed in Figure 1).

Table 1
www.frontiersin.org

Table 1. Particles’ sizes and charges (zeta potential) of fabricated nanomaterials.

3.3 The scanning electron microscope

The SEM and TEM micrograph clearly demonstrate that the material exhibits a uniform dispersion of fine particles, with sizes typically in the nanoscale range (Figure 3). The images also reveal the nearly spherical shape and high resolution of the nanocomposite (Hou et al., 2022).

Figure 3
Two scanning electron microscope images side by side. The left image, labeled

Figure 3. Electron microscopy imaging including scanning feature of Fu/BSt/AgNPs/CS (S) and transmission microscopy image of biosynthesized AgNPs (T).

Imaging of the nanocomposites using SEM (Figure 3S) demonstrates the semi-spherical form of the granules, dispersion, and Ps distribution with an approximate size of 146.6 ± 4.32 nm. The successful formation of NCs confirmed the effectiveness of the newly employed synthesis procedure and may promote the use of this technique to create more NCs from other biological polymers. The primary factor suggested that the strong electrostatic interaction between the charged negative chitosan (CS) and the strongly charged CS is necessary for the efficient synthesis of the present NCs. Fu/BSt/AgNPs, which has been previously observed in other NCs formed through CS combining with biopolymers that are charged to the negative, such as the carrageenan and alginate (El-Sherbiny et al., 2022). The differences in charges between the positive CS and other negatively charged polymers enabled stable NCs formation with improved synergistic biological activity (El-Sherbiny et al., 2022). The size and morphology of AgNPs was captured through TEM analysis (Figure 3T), which appointed the mean diameter of 8.83 ± 1.51 nm of the particles.

3.4 In vitro anticancer biocidal activities of Fu/BSt/AgNPs/CS

The anticancer activity of the nanocomposite against HCT 116 and A375 cells was compared to cisplatin, a standard chemotherapeutic agent. The full IC50 values for all tested compounds across all cancer cell lines are presented in Table 2. The Fu/BSt/AgNPs/CS composite demonstrated the most effective anticancer effect, as demonstrated by the two cancer cell lines’ lowest IC50 values (e.g., 12.75 and 22.44 mg/L, respectively). The IC50 values against HCT 116 and A375 cells were 16.23 and 34.81 mg/L for Fu/BSt/AgNPs, 27.16 and 90.28 mg/L for BSt/AgNPs, 80.61 and 112.76 for BSt, respectively.

Table 2
www.frontiersin.org

Table 2. Anticancer fucoidan (Fu), betasitosterol (BSt), fucoidan with beta sitosterol and silver nanoparticles, and their nanoconjugation with chitosan (Fu/BSt/AgNPs/CS).

Interestingly, the cancer-fighting properties of the Fu/BSt/AgNPs/CS nanocomposite surpassed that of cisplatin (with IC50 of 25.56 and 79.77 mg/L against HCT 116 and A375 cells, respectively).

In contrast, the bare biopolymer CS exhibited lower biocidal activity compared to the Fu/BSt/AgNPs/CS nanocomposite against cancerous cells. The conjugation of nanometals with biopolymer coatings significantly reduced the potential toxicity to mammalian tissues while preserving or even enhancing the bioactivity against cancer cells (El-Sherbiny et al., 2023). The effect of the nanocomposite on HCT 116 colon cancer cells and A375 skin cancer cells, as demonstrated in Figure 4, revealed its cytotoxic potential. The synthesized nanocomposite notably inhibited cell proliferation. In terms of cell migration suppression, A375 and HCT 116 monolayers were exposed to different concentrations of the nanocomposite. After 12 h, treatment with 10, 15, and 20 mg/mL of the nanocomposite significantly reduced the migration rate of both cancer cell lines. After 48 h, the inhibition of cell migration for A375 and HCT 116 cells, respectively, in response to the nanocomposite treatment. Moreover, as the concentration of the nanocomposite increased, the migration inhibition also intensified, showing a clear dose-dependent effect.

Figure 4
Three-panel image showing fluorescent microscopy results. Panel A: Green fluorescent cells against a dark background. Panel B: Mix of green and orange-red fluorescent cells, indicating overlap or interaction. Panel C: Predominantly orange-red fluorescent cells with some green, suggesting a different state or labeling. Each panel is bordered in orange and labeled A, B, and C.

Figure 4. Fluorescent imaging of treated A375 cancer cells with IC50 concentration of Fu/BSt/AgNPs/CS nanocomposites, using dual staining with acridine orange/ethydium bromide, including control cells (A), exposed cells for 24 h (B) and or 48 h (C).

3.5 Appraisal of cell apoptosis via dual staining and fluorescent imaging

The fluorescent imaging of treated A375 cells with Fu/BSt/AgNPs/CS nanocomposites (at IC50 concentration), using dual staining with acridine orange/ethydium bromide, could emphasize the impact of nanocomposite on the induction of apoptosis signs in cancerous cells (Figure 4). The color of control A375 cells was mostly green, without any reddish or orange spots (Figure 4A), which indicate the healthy and active conditions of cancer cells. After cells’ treatment with Fu/BSt/AgNPs/CS nanocomposites for 24 h, notable appearance of orange nuclei in several cells was detected with other cells that turned to reddish, which indicate cells death/apoptosis (Figure 4B). After 48 h of cells’ treatment, the quantity of apoptotic cells (reddish and reddish-orange stained) greatly increased with massive proportions (Figure 4C), which associates with the signs of apoptotic cells appearance. The appearance of apoptosis signs in treated cancer cells with nanocomposites were formerly stated in former investigations to verify the potentiality of nanomaterials for triggering cells death (Alalawy et al., 2020; El-Sherbiny et al., 2023).

3.6 Evaluation of the cytotoxic impact of nanocomposites using SEM

SEM scans revealed that the nanocomposite particles were present on the surface of tumor cells, which would not be visible with conventional light microscopy and required the higher resolution of SEM for detailed observation. These surface structures are critical for understanding cancer biology, as they play vital roles in cell migration, apoptosis, and overall cell function. Furthermore, cells treated with the nanocomposite exhibited clear signs of collapse, including membrane perforations and vacuolization. These deformations, previously observed in cells treated with anticancer agents (Zhang et al., 2024), emphasizing the potential impact of the nanocomposites on cell morphology and function, particularly in cancer treatment.

The HCT 116 cells were chosen for SEM imaging because they were more sensitive to nanocomposites anticancerous action. After treating HCT 116 cells with 2 × IC50 of the Fu/BSt/AgNPs/CS nanocomposite, the anticancer potential of the composite was further examined using SEM imaging (Figure 5). SEM images revealed that control cells had a normal size and shape with intact structures, showing no abnormal features or distortions. In contrast, the treated cells displayed significant changes in cell morphology, including shrinkage, protrusion, and a reduction in cell density. These morphological alterations were accompanied by visible membrane perforations and vacuolization, indicating cell collapse. Such symmetric deformations and distortions are classic signs of cell death, suggesting that the Fu/BSt/AgNPs/CS nanocomposite effectively caused the cancer cells to alter morphologically.

Figure 5
Side-by-side scanning electron microscope images labeled A and B show clusters of spherical particles with rough, textured surfaces at a magnification of three thousand five hundred times. The scale bar indicates five micrometers.

Figure 5. Morphological changes in HCT 116 cancerous cells before (A) and after (B) treatment with nanocomposite using scanning microscope.

4 Conclusion

The synthesized Fu/BSt/AgNPs nanocomposite conjugated with CS demonstrated significant promise as a natural and effective alternative for combating cancer, particularly in the suppression of colorectal (HCT-116) and skin (A375) malignant cells. The anticancer activity of the Fu/BSt/AgNPs/CS nanocomposite was notably superior to that of cisplatin, a conventional chemotherapy agent. Treatment with the nanocomposite led to cytotoxic effects, including apoptosis, reduced cell proliferation, and clear alterations in cell morphology, such as cell shrinkage, blebbing, and membrane perforation. SEM imaging revealed that these structural changes, such as vacuolization and membrane damage, are indicative of effective cell death, further supporting the anticancer potential of the nanocomposite. The bio-based components of the Fu/BSt/AgNPs/CS nanocomposite, combined with its potent anticancer properties, suggest a promising technique for controlling or preventing the growth of malignant cells. These results demonstrate the possibility of such nanocomposites as a viable and less toxic alternative for cancer therapy, with the ability to target tumor cells while minimizing damage to healthy tissues.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.

Ethics statement

Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.

Author contributions

AT: Investigation, Writing – review and editing, Conceptualization, Supervision, Writing – original draft, Methodology. FE: Methodology, Conceptualization, Investigation, Writing – original draft, Formal Analysis. AA: Investigation, Conceptualization, Writing – original draft, Supervision, Writing – review and editing, Data curation. HG: Formal Analysis, Validation, Software, Writing – original draft, Investigation. ME-H: Visualization, Writing – original draft, Resources, Data curation, Funding acquisition. SA: Writing – original draft, Funding acquisition, Project administration, Resources, Data curation. SE-F: Writing – original draft, Funding acquisition, Resources, Data curation, Validation.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article.

Acknowledgments

This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia, under Grant no. (IPP: 1275-662-2025). The authors, therefore, acknowledge with thanks DSR for technical and financial support. The authors would also like to thank the Deanship of Scientific Research, Taif University for this work.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Alalawy, A. I., El Rabey, H. A., Almutairi, F. M., Tayel, A. A., Al-Duais, M. A., Zidan, N. S., et al. (2020). Effectual anticancer potentiality of loaded bee venom onto fungal chitosan nanoparticles. Int. J. Polym. Sci. 2020 (1), 1–9. doi:10.1155/2020/2785304

CrossRef Full Text | Google Scholar

Alvarez-Sala, A., Attanzio, A., Tesoriere, L., Garcia-Llatas, G., Barberá, R., and Cilla, A. (2019). Apoptotic effect of a phytosterol-ingredient and its main phytosterol (β-sitosterol) in human cancer cell lines. Int. J. food Sci. Nutr. 70 (3), 323–334. doi:10.1080/09637486.2018.1511689

PubMed Abstract | CrossRef Full Text | Google Scholar

Alves, F. F., de Jesus, L. C., Cristelli, M. P., Enokihara, M. M. E. S., Hirata, S. H., Facina, A. D. S., et al. (2024). Metastasis of skin squamous cell carcinoma in kidney transplant recipients. Int. J. Dermatology 63 (5), 560–564. doi:10.1111/ijd.17029

PubMed Abstract | CrossRef Full Text | Google Scholar

Aranaz, I., Alcántara, A. R., Civera, M. C., Arias, C., Elorza, B., Heras Caballero, A., et al. (2021). Chitosan: an overview of its properties and applications. Polymers 13 (19), 3256. doi:10.3390/polym13193256

PubMed Abstract | CrossRef Full Text | Google Scholar

Ata, T. E., Al-Ani, I., Karameh, N., Atta, M. R., and Dayyih, W. A. (2025). Alectinib-loaded chitosan–alginate nanoparticles: a novel synthesis method with in vitro and in vivo evaluations. Pharmaceutics 17 (4), 492. doi:10.3390/pharmaceutics17040492

PubMed Abstract | CrossRef Full Text | Google Scholar

Bao, X., Zhang, Y., Zhang, H., and Xia, L. (2022). Molecular mechanism of β-sitosterol and its derivatives in tumor progression. Front. Oncol. 12, 926975. doi:10.3389/fonc.2022.926975

PubMed Abstract | CrossRef Full Text | Google Scholar

Costa, J. A. V., Lucas, B. F., Alvarenga, A. G. P., Moreira, J. B., and de Morais, M. G. (2021). Microalgae polysaccharides: an overview of production, characterization, and potential applications. Polysaccharides 2 (4), 759–772. doi:10.3390/polysaccharides2040046

CrossRef Full Text | Google Scholar

Díaz- Singh, S., Chittasupho, C., Prajapati, B. G., and Chandel, A. S. (2023). Editorial: biodegradable polymeric materials in tissue engineering and their application in drug delivery. Front. Bioeng. Biotechnol. 11, 1296119. doi:10.3389/fbioe.2023.1296119

PubMed Abstract | CrossRef Full Text | Google Scholar

El-Sherbiny, M. M., Elekhtiar, R. S., El-Hefnawy, M. E., Mahrous, H., Alhayyani, S., Al-Goul, S. T., et al. (2022). Fabrication and assessment of potent anticancer nanoconjugates from chitosan nanoparticles, curcumin, and eugenol. Front. Bioeng. Biotechnol. 10, 1030936. doi:10.3389/fbioe.2022.1030936

PubMed Abstract | CrossRef Full Text | Google Scholar

El-Sherbiny, M. M., Orif, M. I., El-Hefnawy, M. E., Alhayyani, S., Al-Goul, S. T., Elekhtiar, R. S., et al. (2023). Fabrication of bioactive nanocomposites from chitosan, cress mucilage, and selenium nanoparticles with powerful antibacterial and anticancerous actions. Front. Microbiol. 14, 1210780. doi:10.3389/fmicb.2023.1210780

PubMed Abstract | CrossRef Full Text | Google Scholar

Forma, E., and Bryś, M. (2021). Anticancer activity of propolis and its compounds. Nutrients 13 (8), 2594. doi:10.3390/nu13082594

PubMed Abstract | CrossRef Full Text | Google Scholar

Hou, L., Zhong, T., Cheng, P., Long, B., Shi, L., Meng, X., et al. (2022). Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer. Front. Bioeng. Biotechnol. 10. ‏doi:10.3389/fbioe.2022.938662

PubMed Abstract | CrossRef Full Text | Google Scholar

Hsiao, W. C., Hong, Y. H., Tsai, Y. H., Lee, Y. C., Patel, A. K., Guo, H. R., et al. (2022). Extraction, biochemical characterization, and health effects of native and degraded fucoidans from Sargassum crispifolium. Polymers 14 (9), 1812. doi:10.3390/polym14091812

PubMed Abstract | CrossRef Full Text | Google Scholar

Islam, M. R., Akash, S., Rahman, M. M., Nowrin, F. T., Akter, T., Shohag, S., et al. (2022). Colon cancer and colorectal cancer: prevention and treatment by potential natural products. Chemico-biological Interact. 368, 110170. doi:10.1016/j.cbi.2022.110170

PubMed Abstract | CrossRef Full Text | Google Scholar

Jhaveri, J., Raichura, Z., Khan, T., Momin, M., and Omri, A. (2021). Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics. Molecules 26 (2), 272. ‏. doi:10.3390/molecules26020272

PubMed Abstract | CrossRef Full Text | Google Scholar

Ji, Z., Tao, S., and Wang, B. (2021). Editorial: artificial intelligence (AI) optimized systems modeling for the deeper understanding of human cancers. Front. Bioeng. Biotechnol. 9, 756314. doi:10.3389/fbioe.2021.756314

PubMed Abstract | CrossRef Full Text | Google Scholar

Jiang, Z., Wang, X., Zhou, Z., Peng, L., Lin, X., Luo, X., et al. (2024). Functional characterization of D-type cyclins involved in cell division in rice. BMC Plant Biol. 24 (1), 157. ‏doi:10.1186/s12870-024-04828-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Jiang, X., Yan-Ran, W., Pin-Ru, D., Shi-Yi, Q., and Haitao, J. (2025). Organoids in cancer therapies: a comprehensive review. Front. Bioeng. Biotechnol. 13, 1607488. ‏doi:10.3389/fbioe.2025.1607488

PubMed Abstract | CrossRef Full Text | Google Scholar

Khan, S., and Anwar, N. (2019). Highly porous ph-responsive carboxymethyl chitosan-grafted-poly (acrylic acid) based smart hydrogels for 5-fluorouracil controlled delivery and colon targeting. Int. J. Polym. Sci. 2019 (1), 1–15. doi:10.1155/2019/6579239

CrossRef Full Text | Google Scholar

Li, D., Zhang, X., Chen, X., and Li, W. (2022). Research progress and prospects for polymeric nanovesicles in anticancer drug delivery. Front. Bioeng. Biotechnol. 10, 850366. doi:10.3389/fbioe.2022.850366

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, Y., Li, X., and Liang, A. (2022). Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis. Front. Bioeng. Biotechnol. 10, 1042128. doi:10.3389/fbioe.2022.1042128

PubMed Abstract | CrossRef Full Text | Google Scholar

López Ruiz, A., Bartomeu Garcia, C., Navarro Gallón, S., and Webster, T. J. (2020). Novel silver-platinum nanoparticles for anticancer and antimicrobial applications. Int. J. Nanomedicine Vol. 15, 169–179. doi:10.2147/ijn.s176737

PubMed Abstract | CrossRef Full Text | Google Scholar

Menon, S., Ks, S. D., Santhiya, R., Rajeshkumar, S., and Kumar, V. (2018). Selenium nanoparticles: a potent chemotherapeutic agent and an elucidation of its mechanism. Colloids Surf. B. Biointerfaces. 170, 280–292. doi:10.1016/j.colsurfb.2018.06.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Namvar, F., Mohamad, R., Baharara, J., Zafar-Balanejad, S., Fargahi, F., and Rahman, H. S. (2013). Antioxidant, antiproliferative, and antiangiogenesis effects of polyphenol-rich seaweed (Sargassum muticum). BioMed Res. Int. 2013 (1), 1–9. doi:10.1155/2013/604787

PubMed Abstract | CrossRef Full Text | Google Scholar

Nandi, S., Nag, A., Khatua, S., Sen, S., Chakraborty, N., Naskar, A., et al. (2024). Anticancer activity and other biomedical properties of β-sitosterol: bridging phytochemistry and current pharmacological evidence for future translational approaches. Phytotherapy Res. 38 (2), 592–619. doi:10.1002/ptr.8061

PubMed Abstract | CrossRef Full Text | Google Scholar

Narayani, S. S., Saravanan, S., Ravindran, J., Ramasamy, M. S., and Chitra, J. (2019). In vitro anticancer activity of fucoidan extracted from Sargassum cinereum against Caco-2 cells. Int. J. Biol. Macromol. 138, 618–628. doi:10.1016/j.ijbiomac.2019.07.127

PubMed Abstract | CrossRef Full Text | Google Scholar

Ododo, M. M., Choudhury, M. K., and Dekebo, A. H. (2016). Structure elucidation of β-sitosterol with antibacterial activity from the root bark of Malva parviflora. SpringerPlus 5 (1), 1210–1211. ‏‏doi:10.1186/s40064-016-2894-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Peate, I. (2021). The skin: largest organ of the body. Br. J. Healthc. Assistants 15 (9), 446–451. doi:10.12968/bjha.2021.15.9.446

CrossRef Full Text | Google Scholar

Ptak, S. H., Sanchez, L., Fretté, X., and Kurouski, D. (2021). Complementarity of raman and infrared spectroscopy for rapid characterization of fucoidan extracts. Plant Methods 17, 130–10. ‏doi:10.1186/s13007-021-00830-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajeshkumar, S. (2017). Phytochemical constituents of fucoidan (Padina tetrastromatica) and its assisted AgNPs for enhanced antibacterial activity. IET nanobiotechnology 11 (3), 292–299. doi:10.1049/iet-nbt.2016.0099

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajeshkumar, S., Sherif, M. H., Malarkodi, C., Ponnanikajamideen, M., Arasu, M. V., Al-Dhabi, N. A., et al. (2021). Cytotoxicity behaviour of response surface model optimized gold nanoparticles by utilizing fucoidan extracted from padina tetrastromatica. J. Mol. Struct. 1228, 129440. doi:10.1016/j.molstruc.2020.129440

CrossRef Full Text | Google Scholar

Rytsyk, O., Soroka, Y., Shepet, I., Vivchar, Z., Andriichuk, I., Lykhatskyi, P., et al. (2020). Experimental evaluation of the effectiveness of resveratrol as an antioxidant in colon cancer prevention. Nat. Product. Commun. 15. ‏doi:10.1177/1934578x20932742

CrossRef Full Text | Google Scholar

Sacramento, M. M., Borges, J., Correia, F. J., Calado, R., Rodrigues, J. M., Patrício, S. G., et al. (2022). Green approaches for extraction, chemical modification and processing of marine polysaccharides for biomedical applications. Front. Bioeng. Biotechnol. 10. doi:10.3389/fbioe.2022.1041102

PubMed Abstract | CrossRef Full Text | Google Scholar

Siegel, R. L., Miller, K. D., Fuchs, H. E., and Jemal, A. (2022). Cancer statistics. CA a cancer J. Clin. 72 (1), 7–33. ‏doi:10.3322/caac.21708

PubMed Abstract | CrossRef Full Text | Google Scholar

Tayel, A. A., Ghanem, R. A., Al-Saggaf, M. S., Elebeedy, D., and Abd El Maksoud, A. I. (2021). Application of Fish collagen-nanochitosan-henna extract composites for the control of skin pathogens and accelerating wound healing. Int. J. Polym. Sci. 2021 (1), 1–9. ‏doi:10.1155/2021/1907914

CrossRef Full Text | Google Scholar

Venkatesan, J., Lee, J. Y., Kang, D. S., Anil, S., Kim, S. K., Shim, M. S., et al. (2017). Antimicrobial and anticancer activities of porous chitosan-alginate biosynthesized silver nanoparticles. Int. J. Biol. Macromol. 98, 515–525. ‏doi:10.1016/j.ijbiomac.2017.01.120

PubMed Abstract | CrossRef Full Text | Google Scholar

Yao, W., Qiu, H. M., Cheong, K. L., and Zhong, S. (2022). Advances in anti-cancer effects and underlying mechanisms of marine algae polysaccharides. Int. J. Biol. Macromol. 221, 472–485. doi:10.1016/j.ijbiomac.2022.09.055

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, H., Wu, W., Lin, X., and Feng, Y. (2020). Polysaccharide-based nanomaterials for ocular drug delivery: a perspective. Front. Bioeng. Biotechnol. 8. ‏doi:10.3389/fbioe.2020.601246

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, H., Zhang, Q., Farooqi, A. A., Wang, J., Yue, Y., Geng, L., et al. (2024). Opportunities and challenges of fucoidan for tumors therapy. Carbohydr. Polym. 324. ‏doi:10.1016/j.carbpol.2023.121555

PubMed Abstract | CrossRef Full Text | Google Scholar

Zahariev, N., Katsarov, P., Lukova, P., and Pilicheva, B. (2023). Novel fucoidan pharmaceutical formulations and their potential application in Oncology—A review. Polymers 15 (15), 3242. doi:10.3390/polym15153242

PubMed Abstract | CrossRef Full Text | Google Scholar

Zayed, A., El-Aasr, M., Ibrahim, A. R. S., and Ulber, R. (2020). Fucoidan characterization: determination of purity and physicochemical and chemical properties. Mar. drugs 18 (11), 571. doi:10.3390/md18110571

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, X. F., Shen, W., and Gurunathan, S. (2016). Silver nanoparticle-mediated cellular responses in various cell lines: an in vitro model. Int. J. Mol. Sci. 17 (10), 1603. doi:10.3390/ijms17101603

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, Z., Lin, S., Liu, Z., Han, J., Li, J., and Yu, Y. (2022). Anticolon cancer targets and molecular mechanisms of tao-he-cheng-qi formula. Evidence-Based Complementary Altern. Med. 2022 (1), 1–22. ‏doi:10.1155/2022/7998664

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, T., Li, X., Wu, L., Su, Y., Yang, J., Zhu, X., et al. (2024). Enhanced cisplatin chemotherapy sensitivity by self-assembled nanoparticles with olaparib. Front. Bioeng. Biotechnol. 12, 1364975. doi:10.3389/fbioe.2024.1364975

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhu, R., Yuan, W., Xia, A., Sun, X., Yan, W., Wu, T., et al. (2024). Inulin-based nanoparticle modulates gut microbiota and immune microenvironment for improving colorectal cancer therapy. Adv. Funct. Mater. 34. doi:10.1002/adfm.202407685

CrossRef Full Text | Google Scholar

Keywords: anticancer activity, biopolymers nanoparticles, biosynthesis, natural products, bioactivity

Citation: Tayel AA, Elagezy FK, Abdella A, Gad HA, El-Hefnawy ME, Alhayyani S and El-Far SW (2025) Construction of bioactive nanocomposites from beta-sitosterol, fucoidan, chitosan, and silver nanoparticles for anticancer applications. Front. Bioeng. Biotechnol. 13:1668888. doi: 10.3389/fbioe.2025.1668888

Received: 18 July 2025; Accepted: 08 October 2025;
Published: 15 October 2025.

Edited by:

Filippo Rossi, Polytechnic University of Milan, Italy

Reviewed by:

Anjali Ravi, Bharathiar University, India
Umar Farooq Gohar, Government College University, Lahore, Pakistan

Copyright © 2025 Tayel, Elagezy, Abdella, Gad, El-Hefnawy, Alhayyani and El-Far. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ahmed A. Tayel, YWhtZWRfdGF5ZWxAZnNoLmtmcy5lZHUuZWc=; Sultan Alhayyani, c2FsaGF5eWFuaUBrYXUuZWR1LnNh

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.